Journal: eLife
Article Title: S100a4 + alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting the angiogenic function regulated by fatty acid metabolism
doi: 10.7554/eLife.101731
Figure Lengend Snippet: ( A ) Determination of intracellular lipid droplet accumulation, mitochondrial membrane potential, and mitochondrial reactive oxygen species (ROS) by flow cytometry, n = 3. ( B ) Tube formation of human umbilical vein endothelial cells (HUVECs) after coculture with S100a4 -OE MH-S, quantified by total tube length and number of nodes, n = 5. Scale bar: 200 µm. ( C ) Western blotting of fatty acid metabolism-related CPT1A in S100a4 -OE MH-S. ( D ) Western blotting of ANXA2 and PLG in S100a4 -OE MH-S and cocultured HUVEC and MLE12. ( E ) CCK8 assay of cocultured MLE12 after treatment of ETO to S100a4 -OE MH-S, n = 6. ( F ) Wound healing assay of cocultured MLE12 after treatment of ETO to S100a4 -OE MH-S, n = 3. Scale bar: 200 µm. ( G ) Intracellular ROS production of cocultured MLE12 after treatment of ETO to S100a4 -OE MH-S, n = 3. ( H ) Tube formation of cocultured HUVECs after treatment of ETO to S100a4 -OE MH-S, n = 3. Scale bar: 200 µm. ( I ) Western blotting of fatty acid metabolism-related proteins (CPT1A and PPAR-γ), angiogenesis-related proteins (ANXA2, VEGF, TGF-β, HIF-1α, and MMP9), and M2 polarization markers (CD206 and ARG1) in S100a4 -OE MH-S after treatment of ETO. ( J ) Western blotting of angiogenesis-related proteins (ANXA2, VEGF, and HIF-1α) in cocultured MLE12 after treatment of ETO to S100a4 -OE MH-S. The results shown above represent three or more replicates. MFI: mean fluorescence intensity; ETO: etomoxir; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Figure 6—source data 1. PDF file containing original western blots for , indicating the relevant bands. Figure 6—source data 2. Original files for western blot analysis displayed in . Figure 6—source data 3. PDF file containing original western blots for , indicating the relevant bands. Figure 6—source data 4. Original files for western blot analysis displayed in . Figure 6—source data 5. PDF file containing original western blots for , indicating the relevant bands. Figure 6—source data 6. Original files for western blot analysis displayed in . Figure 6—source data 7. PDF file containing original western blots for , indicating the relevant bands. Figure 6—source data 8. Original files for western blot analysis displayed in .
Article Snippet: ETO (MedChem Express) was used for targeted inhibition of CPT1A in MH-S.
Techniques: Membrane, Flow Cytometry, Western Blot, CCK-8 Assay, Wound Healing Assay, Fluorescence